Organization
Children's Hospital Los Angeles
22 clinical trials
Clinical trial
Butyrate Therapy in Hispanic Children With Ulcerative ColitisStatus: Recruiting, Estimated PCD: 2027-06-30
Clinical trial
Compassionate Use Pan-VEGF Blockade for the Treatment of ROP (Compassionate Use BLOCK-ROP) TrialStatus:
Clinical trial
Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma, A Phase I StudyStatus: Completed, Estimated PCD: 2010-10-01
Clinical trial
Maralixibat in Patients With Cystic Fibrosis and Constipation, A Within-Subjects Pilot StudyStatus: Not yet recruiting, Estimated PCD: 2026-06-30
Clinical trial
A Randomized Controlled Trial of Three Types of Enemas Used to Treat Functional Constipation in ChildrenStatus: Terminated, Estimated PCD: 2017-12-01
Clinical trial
A Phase I Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic OriginStatus: Completed, Estimated PCD: 2013-02-01
Clinical trial
Campath-1h as Immunoablative Therapy for Children and Adolescents With Treatment Refractory Systemic SclerosisStatus: Withdrawn, Estimated PCD: 2018-08-02
Clinical trial
The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative ColitisStatus: Active (not recruiting), Estimated PCD: 2023-11-01
Clinical trial
Dynamics of Gut Microbiomes in Autism Spectrum Disorder (ASD) SymptomsStatus: Active (not recruiting), Estimated PCD: 2026-03-01
Clinical trial
Pilot Study of Transplant-related Events in Patients Receiving Ultra-high-dose Vitamin D SupplementationStatus: Completed, Estimated PCD: 2020-05-10
Clinical trial
Neurovascular and Neurocognitive Consequences of Iron Deficiency AnemiaStatus: Not yet recruiting, Estimated PCD: 2028-09-01
Clinical trial
A Multi-center, Prospective Study Evaluating the Rate of Inhibitor Recurrence Following Successful ITI in Patients Receiving Ongoing Once Per Weekly Factor VIII Therapy Along With Emicizumab and in Patients Who Discontinue FVIII Therapy and Are on Emicizumab for ProphylaxisStatus: Active (not recruiting), Estimated PCD: 2024-09-20
Clinical trial
Phase I-II Study of MEK 162 for Children With Low-Grade Gliomas and Other Ras/Raf/ERK Pathway Activated TumorsStatus: Active (not recruiting), Estimated PCD: 2022-11-02
Clinical trial
A Randomized Trial of Postoperative Steroid Use Following Posterior Spinal Fusion in 100-subject Adolescent Idiopathic Scoliosis (AIS) and Neuromuscular Scoliosis (NMS)Status: Not yet recruiting, Estimated PCD: 2024-04-01
Clinical trial
RAPID Feasibility Study: A Pilot Study for the Rapid Infusion of DinutuximabStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation SyndromeStatus: Terminated, Estimated PCD: 2016-05-11
Clinical trial
Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell AnemiaStatus: Not yet recruiting, Estimated PCD: 2028-07-01
Clinical trial
Cerebrovascular Reserve and White Matter Disease in Patients With Chronic AnemiaStatus: Completed, Estimated PCD: 2022-12-31
Clinical trial
Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder in Patients With Recurrent or Resistant NeuroblastomaStatus: Completed, Estimated PCD: 2014-03-01
Clinical trial
I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk NeuroblastomaStatus: Completed, Estimated PCD: 2012-12-01
Clinical trial
A Dose-Finding Study of N-Acetylcysteine (NAC) to Prevent Cisplatin-induced Hearing Loss in Children With CancerStatus: Completed, Estimated PCD: 2020-09-01
Clinical trial
A Sequential Multiple Assignment Randomized Trial (SMART) Assessing Medication and CBT Sequencing Strategies in the Treatment of Predominantly Ethnic Minority, Underserved Youth With Anxiety DisordersStatus: Active (not recruiting), Estimated PCD: 2024-12-01